264 related articles for article (PubMed ID: 16483555)
1. Neonatal 3,4-methylenedioxymethamphetamine (MDMA) exposure alters neuronal protein kinase A activity, serotonin and dopamine content, and [35S]GTPgammaS binding in adult rats.
Crawford CA; Williams MT; Kohutek JL; Choi FY; Yoshida ST; McDougall SA; Vorhees CV
Brain Res; 2006 Mar; 1077(1):178-86. PubMed ID: 16483555
[TBL] [Abstract][Full Text] [Related]
2. Neonatal 3,4-methylenedioxymethamphetamine (ecstasy) alters dopamine and serotonin neurochemistry and increases brain-derived neurotrophic factor in the forebrain and brainstem of the rat.
Koprich JB; Campbell NG; Lipton JW
Brain Res Dev Brain Res; 2003 Dec; 147(1-2):177-82. PubMed ID: 14741762
[TBL] [Abstract][Full Text] [Related]
3. Short-term effects of 3,4-methylen-dioxy-metamphetamine (MDMA) on 5-HT(1A) receptors in the rat hippocampus.
Giannaccini G; Betti L; Pirone A; Palego L; Fabiani O; Fabbrini L; Mascia G; Giusti L; Macchia M; Giusiani M; Martini C; Lucacchini A
Neurochem Int; 2007 Dec; 51(8):496-506. PubMed ID: 17602794
[TBL] [Abstract][Full Text] [Related]
4. Sensitization to MDMA locomotor effects and changes in the functionality of 5-HT(2A) and D₂ receptors in mice.
Varela MJ; Brea J; Loza MI; Maldonado R; Robledo P
Behav Pharmacol; 2011 Aug; 22(4):362-9. PubMed ID: 21712712
[TBL] [Abstract][Full Text] [Related]
5. Acutely applied MDMA enhances long-term potentiation in rat hippocampus involving D1/D5 and 5-HT2 receptors through a polysynaptic mechanism.
Rozas C; Loyola S; Ugarte G; Zeise ML; Reyes-Parada M; Pancetti F; Rojas P; Morales B
Eur Neuropsychopharmacol; 2012 Aug; 22(8):584-95. PubMed ID: 22209363
[TBL] [Abstract][Full Text] [Related]
6. Effect of repeated ('binge') dosing of MDMA to rats housed at normal and high temperature on neurotoxic damage to cerebral 5-HT and dopamine neurones.
Sanchez V; O'shea E; Saadat KS; Elliott JM; Colado MI; Green AR
J Psychopharmacol; 2004 Sep; 18(3):412-6. PubMed ID: 15358986
[TBL] [Abstract][Full Text] [Related]
7. Altered forebrain neurotransmitter responses to immobilization stress following 3,4-methylenedioxymethamphetamine.
Matuszewich L; Filon ME; Finn DA; Yamamoto BK
Neuroscience; 2002; 110(1):41-8. PubMed ID: 11882371
[TBL] [Abstract][Full Text] [Related]
8. Methamphetamine exposure during the preweanling period causes prolonged changes in dorsal striatal protein kinase A activity, dopamine D2-like binding sites, and dopamine content.
Crawford CA; Williams MT; Newman ER; McDougall SA; Vorhees CV
Synapse; 2003 Jun; 48(3):131-7. PubMed ID: 12645038
[TBL] [Abstract][Full Text] [Related]
9. 3,4-methylenedioxymethamphetamine (MDMA) administration to rats decreases brain tissue serotonin but not serotonin transporter protein and glial fibrillary acidic protein.
Wang X; Baumann MH; Xu H; Rothman RB
Synapse; 2004 Sep; 53(4):240-8. PubMed ID: 15266556
[TBL] [Abstract][Full Text] [Related]
10. A study of the neurotoxic effect of MDMA ('ecstasy') on 5-HT neurones in the brains of mothers and neonates following administration of the drug during pregnancy.
Colado MI; O'Shea E; Granados R; Misra A; Murray TK; Green AR
Br J Pharmacol; 1997 Jun; 121(4):827-33. PubMed ID: 9208155
[TBL] [Abstract][Full Text] [Related]
11. Locomotor stimulation produced by 3,4-methylenedioxymethamphetamine (MDMA) is correlated with dialysate levels of serotonin and dopamine in rat brain.
Baumann MH; Clark RD; Rothman RB
Pharmacol Biochem Behav; 2008 Aug; 90(2):208-17. PubMed ID: 18403002
[TBL] [Abstract][Full Text] [Related]
12. 3,4-Methylenedioxymethamphetamine enhances the release of acetylcholine in the prefrontal cortex and dorsal hippocampus of the rat.
Nair SG; Gudelsky GA
Psychopharmacology (Berl); 2006 Jan; 184(2):182-9. PubMed ID: 16378215
[TBL] [Abstract][Full Text] [Related]
13. Disposition of methylenedioxymethamphetamine and three metabolites in the brains of different rat strains and their possible roles in acute serotonin depletion.
Chu T; Kumagai Y; DiStefano EW; Cho AK
Biochem Pharmacol; 1996 Mar; 51(6):789-96. PubMed ID: 8602874
[TBL] [Abstract][Full Text] [Related]
14. Effect of 3,4-methylenedioxymethamphetamine (MDMA) on hippocampal dopamine and serotonin.
Shankaran M; Gudelsky GA
Pharmacol Biochem Behav; 1998 Dec; 61(4):361-6. PubMed ID: 9802829
[TBL] [Abstract][Full Text] [Related]
15. Protein kinase C inhibition differentially affects 3,4-methylenedioxymethamphetamine-induced dopamine release in the striatum and prefrontal cortex of the rat.
Nair SG; Gudelsky GA
Brain Res; 2004 Jul; 1013(2):168-73. PubMed ID: 15193525
[TBL] [Abstract][Full Text] [Related]
16. Prenatal 3,4-methylenedioxymethamphetamine (ecstasy) alters exploratory behavior, reduces monoamine metabolism, and increases forebrain tyrosine hydroxylase fiber density of juvenile rats.
Koprich JB; Chen EY; Kanaan NM; Campbell NG; Kordower JH; Lipton JW
Neurotoxicol Teratol; 2003; 25(5):509-17. PubMed ID: 12972064
[TBL] [Abstract][Full Text] [Related]
17. Direct effects of 3,4-methylenedioxymethamphetamine (MDMA) on serotonin or dopamine release and uptake in the caudate putamen, nucleus accumbens, substantia nigra pars reticulata, and the dorsal raphé nucleus slices.
Iravani MM; Asari D; Patel J; Wieczorek WJ; Kruk ZL
Synapse; 2000 Jun; 36(4):275-85. PubMed ID: 10819905
[TBL] [Abstract][Full Text] [Related]
18. Effects of "Legal X" piperazine analogs on dopamine and serotonin release in rat brain.
Baumann MH; Clark RD; Budzynski AG; Partilla JS; Blough BE; Rothman RB
Ann N Y Acad Sci; 2004 Oct; 1025():189-97. PubMed ID: 15542717
[TBL] [Abstract][Full Text] [Related]
19. Sex differences in the neurochemical and functional effects of MDMA in Sprague-Dawley rats.
Walker QD; Williams CN; Jotwani RP; Waller ST; Francis R; Kuhn CM
Psychopharmacology (Berl); 2007 Jan; 189(4):435-45. PubMed ID: 17019566
[TBL] [Abstract][Full Text] [Related]
20. N-tert-butyl-alpha-phenylnitrone protects against 3,4-methylenedioxymethamphetamine-induced depletion of serotonin in rats.
Yeh SY
Synapse; 1999 Mar; 31(3):169-77. PubMed ID: 10029234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]